Kisho is an information platform, not a medical provider. Nothing on this site constitutes medical advice, diagnosis, or treatment recommendations. All content is aggregated from publicly available sources (including ClinicalTrials.gov, PubMed, FDA.gov, and Orphanet) and is provided for informational purposes only. Clinical trial eligibility, treatment decisions, and any health-related actions should always be discussed with a qualified healthcare professional. Kisho does not endorse any specific therapy, organization, or clinical trial. Terms of use · Privacy policy
A syndromic neurodevelopmental disorder characterized by delayed psychomotor development, intellectual disability, truncal hypotonia, spasticity, and peripheral neuropathy.
Features include always present findings: Low muscle tone (hypotonia) and Global developmental delay; and very common findings: Intellectual disability and Increased circulating lactate concentration. 35 total HPO annotations.
Organ System | Phenotype Count | Example Features |
|---|---|---|
Brain and nerves | 10 | Peripheral axonal neuropathy, Inability to walk, Dystonia |
ATAD3A encodes ATPase family AAA domain containing 3A (586 aa). Essential for mitochondrial network organization, mitochondrial metabolism and cell growth at organism and cellular level. May play an important role in mitochondrial protein synthesis. Highest expression in Cells EBV-transformed lymphocytes (34.4 TPM) and Cells Cultured fibroblasts (32.1 TPM).
Harel-Yoon syndrome is associated with mutations in the ATAD3A gene on chromosome 1.
ATAD3A is classified as a druggable target with score 0.0.
Genetic testing for ATAD3A is available. Testing is considered confirmatory for diagnosis.
Biomarker and diagnostic research for Harel-Yoon syndrome has been reported in the published literature.
Phenotype severity distribution: 2 always present features, 2 very common features, 10 common features.
Estimated prevalence: <1 in 1,000,000 (VERY_RARE).
No clinical trials have been registered for Harel-Yoon syndrome.
105 publications have been identified in PubMed for Harel-Yoon syndrome. Kisho has analyzed 68 by research type. Research spans Basic Science / Preclinical (31%), Case Report / Case Series (22%), and Review / Meta-Analysis (18%).
Research Type | Count | % of Total |
|---|---|---|
Laboratory research | 21 | 31% |
Data assembled from 6 of 12 sources · Last updated Sep 20, 2026, 1:13 PM UTC
Online Mendelian Inheritance in Man
European rare disease database
Genetic and Rare Diseases Info Center
Common questions about Harel-Yoon syndrome
Eyes |
4 |
Cloudy or opaque cornea (corneal opacity), Nystagmus, Developmental cataract |
Muscles | 4 | Shrinkage of the cerebellum (cerebellar atrophy), Low muscle tone (hypotonia), Axial hypotonia |
Head and neck | 2 | Long face, Mandibular prognathia |
Bones and joints | 1 | Sideways curvature of the spine (scoliosis) |
Digestive system | 1 | Feeding difficulties |
Lab test results | 1 | Increased circulating lactate concentration |
Heart and blood vessels | 1 | Thickened heart muscle (hypertrophic cardiomyopathy) |
Age of onset: before birth.
Patient case studies
15 |
22% |
Research summaries | 12 | 18% |
Disease patterns and progression | 10 | 15% |
Clinical study results | 4 | 6% |
New treatment approaches | 4 | 6% |
Testing and diagnosis research | 2 | 3% |
Morison LD (2026). [PMID: 40379967](https://pubmed.ncbi.nlm.nih.gov/40379967/). *European journal of human genetics : EJHG*. [Case Report / Case Series]
Doctor MB (2026). [PMID: 40468687](https://pubmed.ncbi.nlm.nih.gov/40468687/). *Seminars in ophthalmology*. [Gene Therapy / Novel Therapeutics]
Zhang MJ (2025). [PMID: 40048124](https://pubmed.ncbi.nlm.nih.gov/40048124/). *World journal of pediatrics : WJP*. [Basic Science / Preclinical]
Yang Q (2025). [PMID: 41401963](https://pubmed.ncbi.nlm.nih.gov/41401963/). *Zhongguo dang dai er ke za zhi = Chinese journal of contemporary pediatrics*. [Case Report / Case Series]
Hamanaka K (2025). [PMID: 40858643](https://pubmed.ncbi.nlm.nih.gov/40858643/). *NPJ genomic medicine*. [Case Report / Case Series]
Pillarisetti L (2025). [PMID: 39902055](https://pubmed.ncbi.nlm.nih.gov/39902055/). *Archives of internal medicine research*. [Review / Meta-Analysis]
Bakur K (2025). [PMID: 41024252](https://pubmed.ncbi.nlm.nih.gov/41024252/). *Genome medicine*. [Clinical Trial Publication]
Belfeki N (2025). [PMID: 40383683](https://pubmed.ncbi.nlm.nih.gov/40383683/). *European journal of internal medicine*. [Review / Meta-Analysis]
AlTassan R (2025). [PMID: 40508110](https://pubmed.ncbi.nlm.nih.gov/40508110/). *International journal of molecular sciences*. [Basic Science / Preclinical]
Bergstrom R (2025). [PMID: 40773218](https://pubmed.ncbi.nlm.nih.gov/40773218/). *Journal of neuro-ophthalmology : the official journal of the North American Neuro-Ophthalmology Society*. [Epidemiology / Natural History]